Skip to main content
CTNM logo

CTNM

Contineum Therapeutics, Inc.
$15.10 -0.14 (-0.92%) At close · Jul 2
Market Cap
$644.97M
Shares
37,386,377

Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.

Filed Seller Shares
2026-07-01 Daniel Lorrain 9,520
2026-06-30 CARMINE STENGONE 10,000
2026-06-30 TIMOTHY WATKINS 10,833
2026-06-30 Daniel Lorrain 28,826
2026-06-01 DANIEL LORRAIN 4,170
2026-05-01 DANIEL LORRAIN 4,170
2026-04-06 DANIEL LORRAIN 914
2026-02-11 DANIEL LORRAIN 16,050
2026-02-11 CARMINE STENGONE 7,500
2026-02-03 DANIEL LORRAIN 4,170
2026-01-05 DANIEL LORRAIN 4,170
2025-12-29 TIMOTHY WATKINS 10,833
2025-12-23 DANIEL LORRAIN 4,170
2024-11-18 DANIEL LORRAIN 26,370
Showing 1–14 of 14 filings
Key facts CIK 1855175 CUSIP 21217B100 Visit website Investor relations